IMMUNE-MEDIATED UVEITIS

IMMUNE-MEDIATED UVEITIS was reported 183 times

IMMUNE-MEDIATED UVEITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CTLA-4-directed Blocking Antibody [EPC] 82 0.0017
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 128 0.0013
2 Microtubule Inhibitor [EPC] 8 0.0000
3 Platinum-based Drug [EPC] 13 0.0000
4 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
5 Vascular Endothelial Growth Factor Inhibitor [EPC] 4 0.0000
6 beta3-Adrenergic Agonist [EPC] 1 0.0000
7 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
8 Tetracycline-class Drug [EPC] 1 0.0000
9 Aldosterone Antagonist [EPC] 2 0.0000
10 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
11 Prostaglandin Analog [EPC] 1 0.0000
12 Osmotic Laxative [EPC] 3 0.0000
13 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
14 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
15 Fluoroquinolone Antibacterial [EPC] 1 0.0000
16 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
17 alpha-Adrenergic Blocker [EPC] 1 0.0000
18 Loop Diuretic [EPC] 3 0.0000
19 Thiazide Diuretic [EPC] 1 0.0000
20 Corticosteroid [EPC] 6 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
22 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
23 Proton Pump Inhibitor [EPC] 2 0.0000
24 Vitamin D [EPC] 1 0.0000
25 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
26 Vitamin B12 [EPC] 1 0.0000
27 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
28 Vitamin C [EPC] 1 0.0000
29 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
30 Kinase Inhibitor [EPC] 1 0.0000